196 related articles for article (PubMed ID: 34238422)
1. [Roles of Myeloid-derived Suppressor Cells in Breast Cancer Metastasis].
Peng XY; Li Y; Xu ZL; Guo Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Jun; 43(3):445-451. PubMed ID: 34238422
[TBL] [Abstract][Full Text] [Related]
2. CXCL17-derived CD11b
Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
[TBL] [Abstract][Full Text] [Related]
3. Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche.
Xia C; Bai W; Deng T; Li T; Zhang L; Lu Z; Zhang Z; Li M; He Q
Acta Biomater; 2023 Mar; 158():708-724. PubMed ID: 36638937
[TBL] [Abstract][Full Text] [Related]
4. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
[TBL] [Abstract][Full Text] [Related]
5. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.
Oh K; Lee OY; Shon SY; Nam O; Ryu PM; Seo MW; Lee DS
Breast Cancer Res; 2013; 15(5):R79. PubMed ID: 24021059
[TBL] [Abstract][Full Text] [Related]
6. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.
Safarzadeh E; Orangi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2018 Apr; 233(4):3024-3036. PubMed ID: 28661031
[TBL] [Abstract][Full Text] [Related]
8. MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation.
Wang Y; Ding Y; Guo N; Wang S
Front Immunol; 2019; 10():172. PubMed ID: 30792719
[TBL] [Abstract][Full Text] [Related]
9. MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target.
Liu H; Wang Z; Zhou Y; Yang Y
Front Immunol; 2023; 14():1199273. PubMed ID: 37465670
[TBL] [Abstract][Full Text] [Related]
10. MDSCs: The Key Players in the Formation of Pre-Metastatic Niche.
Cui W; Wang Z; Lv J; Qin Y; Shi H
Front Biosci (Landmark Ed); 2023 Mar; 28(3):58. PubMed ID: 37005751
[TBL] [Abstract][Full Text] [Related]
11. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond.
Pastaki Khoshbin A; Eskian M; Keshavarz-Fathi M; Rezaei N
Arch Immunol Ther Exp (Warsz); 2019 Apr; 67(2):89-102. PubMed ID: 30386868
[TBL] [Abstract][Full Text] [Related]
12. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
13. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.
Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X
Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671
[TBL] [Abstract][Full Text] [Related]
14. Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment.
Sceneay J; Griessinger CM; Hoffmann SHL; Wen SW; Wong CSF; Krumeich S; Kneilling M; Pichler BJ; Möller A
PLoS One; 2018; 13(4):e0196040. PubMed ID: 29677215
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway.
Lin Q; Ren L; Jian M; Xu P; Li J; Zheng P; Feng Q; Yang L; Ji M; Wei Y; Xu J
Cell Death Dis; 2019 Sep; 10(10):693. PubMed ID: 31534132
[TBL] [Abstract][Full Text] [Related]
16. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
Front Immunol; 2020; 11():613215. PubMed ID: 33679700
[TBL] [Abstract][Full Text] [Related]
17. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cells-new and exciting players in lung cancer.
Yang Z; Guo J; Weng L; Tang W; Jin S; Ma W
J Hematol Oncol; 2020 Jan; 13(1):10. PubMed ID: 32005273
[TBL] [Abstract][Full Text] [Related]
19. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
[TBL] [Abstract][Full Text] [Related]
20. Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis.
Wang Z; Xiong S; Mao Y; Chen M; Ma X; Zhou X; Ma Z; Liu F; Huang Z; Luo Q; Ouyang G
J Pathol; 2016 Aug; 239(4):484-95. PubMed ID: 27193093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]